Avataxher: An Open-Label, Randomized, Multicenter Study Investigating The Addition Of Bevacizumab (B) To Neoadjuvant Trastuzumab (T) Plus Docetaxel (D) In Patients With Early Stage Her2-Positive Breast Cancer (Her2+Bc) Stratified According To Pet Change After One Therapy Cycle.

JOURNAL OF CLINICAL ONCOLOGY(2014)

引用 5|浏览23
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要